We have detected that you are using Internet Explorer to visit this website. Internet Explorer is now being phased out by Microsoft. As a result, NHS Digital no longer supports any version of Internet Explorer for our web-based products, as it involves considerable extra effort and expense, which cannot be justified from public funds. Some features on this site will not work. You should use a modern browser such as Edge, Chrome, Firefox, or Safari. If you have difficulty installing or accessing a different browser, contact your IT support team.
Prescribing for Diabetes in England - 2005/06 to 2015/16Official statistics
- Publication Date:
- 3 Aug 2016
- Geographic Coverage:
- Geographical Granularity:
- Country, Primary Care Trusts, Clinical Commissioning Groups, Primary Care Organisations
- Date Range:
- 01 Apr 2005 to 31 Mar 2016
Prescribing for Diabetes reports on and examines prescribing trends on medicines prescribed in primary care in England for the treatment and monitoring of diabetes during the period April 2005 to March 2016. Diabetes is a high profile clinical area, as the prevalence is increasing and costs associated with treating patients with diabetes are also increasing.
- Drugs used in diabetes (British National Formulary (BNF) section 6.1) now make up 10.6 per cent of total primary care net ingredient costs (NIC) and 4.6 per cent of prescription items.
- In the financial year 2015/16 there were 49.7 million items prescribed for diabetes at a total net ingredient cost of £956.7 million. Up from 27.1 million prescription items and £513.9 million in 2005/06.
- Antidiabetic drugs (BNF section 6.1.2) make up 44.2 per cent of the total £956.7 million net ingredient cost of drugs used in diabetes. 71.3 per cent of prescription items for diabetes.
NHS BSA, Quality and Outcomes Framework,ePACT, QOF, NDA